Category: Technology Licenses
Created On: 2022-04-28
Record Count: 6
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 1508
IPSCIO Record ID: 66786
IPSCIO Record ID: 178742
Product A once daily ketoprofen product that will be the rated A/B substitutable for Oruvail 200 by the United States Food and Drug Administration.
Ketoprofen is generally prescribed for arthritis-related inflammatory pains or severe toothaches that result in the inflammation of the gums.
IPSCIO Record ID: 5599
IPSCIO Record ID: 4380
The Licensed Technology relates to methods and apparatus for producing APIs having an average particle size of 1,000 nanometers or less, including nano-milling methods and apparatus and pharmacoactive compositions of matter having an particle size of 1,000 nanometers or less and methods for their use.
The reformulation efforts as to IndocinÂ®/IndocidÂ® and the Initial Selected Compounds shall be performed in accordance with the milestones specified.
Indocin is a nonsteroidal anti-inflammatory drug (NSAID).
IPSCIO Record ID: 26558
Indaflex is a topical NSAID formulation intended to be used in the treatment of arthritis. Indaflex is our only prescription drug at the clinical trial stage.